Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population

Translational Research

Volumn 151, Issue 3, 2008, Pages 162-167

  Ejarque, Ismael ^a   Real, Jose T ^a   Martinez Hervas, Sergio ^a   Chaves, F Javier ^a   Blesa, Sebastian ^a   Garcia Garcia, Ana B ^a   Millan, Enrique ^b   Ascaso, Juan F ^a   Carmena, Rafael ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Fundacion Investigacion Hospital Clinico Universitario ^*

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; AGED; APOB GENE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE; HUMAN; LIGAND BINDING; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 38949092098     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.12.001     Document Type: Article

References (27)

1. Goldstein J.L., Hobbs H.H., and Brown M.S. Familial hypercholesterolemia. In: Scriver C.R. (Ed). The metabolic and molecular bases of inherited disease (2001), McGraw Hill, New York 2863-2913
2. Hoeg J.M. Homozygous familial hypercholesterolemia: a paradigm for phenotypic variation. Am J Cardiol 72 (1993) 11D-14D
3. Gudnason V., Day I.N.M., and Humphries S.E. Effect on plasma lipid levels of different classes of mutations in the low-density lipoprotein receptor gene in patients with familial hypercholesterolemia. Arterioscler Thromb 17 (1994) 1717-1722
4. Myant N.B. Familial defective apolipoprotein B-100: a review, including some comparison with familial hypercholesterolemia. Atherosclerosis 104 (1993) 1-18
5. Pullinger C.R., Hennessy L.K., Chatterton J.E., et al. Familial ligand-defective apolipoprotein B: identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 95 (1995) 1225-1234
6. Gaffney D., Reid J.M., Cameron I.M., et al. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidaemia. Arterioscle Thromb Vasc Biol 15 (1995) 1025-1029
7. Rauh G., Keller C., Schuster H., Wolfram G., and Zollner N. Familial defective apolipoprotien B-100: a common cause of primary hyperlipemia. Clin Invest 70 (1992) 77-84
8. Real J.T., Chaves F.J., Ascaso J.F., Armengod M.E., and Carmena R. Estudio del defecto familiar de la apo B-100 en sujetos con el diagnóstico clínico de hipercolesterolemia primaria: identificación de la primera familia afectada en España. Med Clin (Barna) 113 (1999) 15-17
9. Human Genetic Program, Division of Noncomunicable Diseases. Familial hypercholesterolemia, FH Report of WHO consultation (1997), World Health Organization, Geneva, Switzerland 1-45
10. Real J.T., Chaves J.F., Martín de Llano J.J., et al. Identificación y caracterización del primer homocigoto español con defecto familiar de unión de la apolipoproteina B. Med Clin (Barna) 116 (2001) 138-141
11. Allain C.C., Poon L.S., Chan C.S.G., Richmond W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
12. Ter Welle H.F., Baartscheer T., and Fiolet J.W.T. Influence of free glycerol on enzymatic evaluation of triglycerides. Clin Chem 30 (1984) 1102-1103
13. Burstein M., Scholnick H.R., and Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11 (1970) 583-595
14. Havel R.J., Eder H.J., and Bragdon J.H. The distribution and chemical composition of centrifugally separated lipoproteins in human serum. Eur J Clin Invest 34 (1995) 13455
15. Rosseneu M., Vercaemst R., Steinberg K.K., and Cooper G.R. Some considerations of methodology and standarization of apolipoprotein B immunoassays. Clin Chem 29 (1983) 427-433
16. Tilzer L., Thomas S., and Moreno R.F. Use of silica gel polymer for DNA extraction with organic solvents. Anal Biochem 183 (1989) 13-15
17. Chaves F.J., Real J.T., García-García A.B., et al. Large rearrangements of the LDL receptor gene and lipid profile in a Spanish population. Eur J Clin Invest 31 (2001) 309-317
18. García-García A.B., Real J.T., Puig O., et al. Molecular genetics of familial hypercholesterolemia in Spain: ten novel LDLR mutations and population analysis. Hum Mutat 454 (2001) 1-9
19. Schuster H., Rauh G., Müller S., Keller C., Wolfram G., and Zöllner N. Allele specific and asymetric Polymerase chain reaction amplification in combination: a step polymerase chain reaction protocol for rapid diagnosis of familial defective apolipoprotein B-100. Ann Bioch 204 (1992) 22-25
20. Hixon J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31 (1990) 545-548
21. Corella D., Guillen M., Portoles O., et al. Gender specific association of the Trp64Arg mutation in the beta3-adrenargic receptor gene with obesity related phenotypes in a Mediterranean population: interaction with a common lipoprotein gene variation. J Intern Med 250 (2001) 348-360
22. Graham C.A., McClean E., Ward A.J., et al. Mutation screening and genotype: phenotype correlation in familial hypercholesterolemia. Atherosclerosis 147 (1999) 309-316
23. Schaefer J.R., Scharnagl H., Baumstark M.W., et al. Homozygous familial defective apolipoprotein B 100. Enhaced removal of apolipoprotein E containing VLDLs and decreased production of LDLs. Arterioscler Thromb Vasc Biol 17 (1997) 348-353
24. Pietzsch J., Wiedemann B., Julius U., et al. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach. J Lipid Res 37 (1996) 2074-2087
25. März W., Ruzicka V., Pohl T., Usadel K.H., and Gross W. Familial defective apolipoprotein B-100: mild hypercholesterolemia without atherosclerosis in a homozygous patient. Lancet 340 (1992) 1362
26. Schaefer J.R., Winkler K., Schweer H., et al. Increased production of HDL ApoA-I in homozygous familial defective apoB-100. Arterioscler Thromb Vasc Biol 20 (2000) 1796-1799
27. Gallagher J.J., and Myant N.B. Variable expression of the mutation in familial defective apolipoprotein B-100. Arterioscler Thromb 13 (1993) 973-976